We are live on ! Find out more
NA

NewEdge Advisors Portfolio holdings

AUM $33.6B
1-Year Est. Return 31.03%
This Fund
S&P 500
This Quarter Est. Return
-2.83%
1 Year Est. Return
+31.03%
3 Year Est. Return
+88.03%
5 Year Est. Return
+105.56%
10 Year Est. Return
+304.34%
AUM
$9.1B
AUM Growth
+$251M
Cap. Flow
+$577M
Cap. Flow %
6.34%
Top 10 Hldgs %
17.16%
Holding
3,727
New
244
Increased
1,296
Reduced
1,187
Closed
271

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$42.2M
2
IVV icon
iShares Core S&P 500 ETF
IVV
+$41.7M
3
SBUX icon
Starbucks
SBUX
+$28.9M
4
CAT icon
Caterpillar
CAT
+$27.6M
5
AVGO icon
Broadcom
AVGO
+$27.5M

Sector Composition

Rank Sector Weight
1 Miscellaneous 56.32%
2 Technology 12.33%
3 Financials 5.59%
4 Healthcare 5.58%
5 Consumer Discretionary 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTCO
3351
DELISTED
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
$127 ﹤0.01%
22
+20
+1,000% +$133
VIVS
3352
VivoSim Labs
VIVS
$3.68M
$125 ﹤0.01%
8
-9
-53% -$159
SPRO icon
3353
Spero Therapeutics
SPRO
$68.1M
$121 ﹤0.01%
100
LGND icon
3354
Ligand Pharmaceuticals
LGND
$5.74B
$120 ﹤0.01%
2
BEEM icon
3355
Beam Global
BEEM
$30.9M
$118 ﹤0.01%
16
-200
-93% -$1.87K
BFLY icon
3356
Butterfly Network
BFLY
$1.99B
$118 ﹤0.01%
100
LNN icon
3357
Lindsay Corp
LNN
$1.23B
$118 ﹤0.01%
1
HDGE icon
3358
AdvisorShares Ranger Equity Bear ETF
HDGE
$53.2M
$117 ﹤0.01%
5
-75,306
-100% -$1.64M
RYTM icon
3359
Rhythm Pharmaceuticals
RYTM
$6.96B
$115 ﹤0.01%
+5
New +$112
KPRX icon
3360
Kiora Pharmaceuticals
KPRX
$11M
$114 ﹤0.01%
22
CRDF icon
3361
Cardiff Oncology
CRDF
$81.7M
$113 ﹤0.01%
81
NMRD
3362
DELISTED
Nemaura Medical, Inc. Common Stock
NMRD
$113 ﹤0.01%
360
VIAV icon
3363
Viavi Solutions
VIAV
$9.67B
$110 ﹤0.01%
12
BBC icon
3364
Virtus Biotech Clinical Trials ETF
BBC
$48.9M
$98 ﹤0.01%
5
NTLA icon
3365
Intellia Therapeutics
NTLA
$1.71B
$95 ﹤0.01%
3
-333
-99% -$12.9K
SABS icon
3366
SAB Biotherapeutics
SABS
$317M
$91 ﹤0.01%
15
SLE icon
3367
Super League Enterprise
SLE
$212M
0
OGI
3368
Organigram Holdings
OGI
$159M
$86 ﹤0.01%
65
+40
+160% +$60
NUS icon
3369
Nu Skin
NUS
$236M
$85 ﹤0.01%
4
GSWO
3370
Goldman Sachs ActiveBeta World Equity ETF
GSWO
$1.78B
$80 ﹤0.01%
+2
New +$82
ITRM
3371
DELISTED
Iterum Therapeutics
ITRM
$80 ﹤0.01%
100
BNGO icon
3372
Bionano Genomics
BNGO
$13.9M
0
SSTK icon
3373
Shutterstock
SSTK
$187M
$79 ﹤0.01%
2
-100
-98% -$4.48K
TONX
3374
TON Strategy Co
TONX
$170M
$79 ﹤0.01%
1
SABSW icon
3375
SAB Biotherapeutics Warrant
SABSW
$169K
$75 ﹤0.01%
1,072

Similar funds

NewEdge Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, NewEdge Advisors held 3,727 positions worth $9.1B, up 2.8% from $8.85B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

NewEdge Advisors deployed $577M of net new capital in Q3 2023, opening 244 new positions and adding to 1,296 existing holdings. Its largest new stake was Xtrackers MSCI EAFE Hedged Equity ETF: 309,492 shares worth $10.8M.

By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 56% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was United Parcel Service, an estimated $26M trimmed.

  • NewEdge Advisors's largest Q3 2023 buy was Xtrackers MSCI EAFE Hedged Equity ETF: 309,492 shares worth $10.8M.
  • NewEdge Advisors added most to Apple in Q3 2023, an estimated $42.2M increase.
  • NewEdge Advisors's biggest Q3 2023 reduction was United Parcel Service, cutting an estimated $26M.
  • NewEdge Advisors fully exited Simplify Interest Rate Hedge ETF in Q3 2023, selling an estimated $8.35M.
  • NewEdge Advisors's ten largest holdings make up 17% of its $9.1B portfolio in Q3 2023.
  • NewEdge Advisors opened 244 new positions and closed 271 in Q3 2023.
  • NewEdge Advisors's portfolio value rose 2.8% quarter-over-quarter to $9.1B.

Based on NewEdge Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.